🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We hope you enjoyed our roundtable on the latest developments in treating early #NSCLC with Jean Yannis Perentes, together with Jonathan Spicer MD PhD, Martin Reck and Salma Jabbour 🧑‍⚕️👩‍⚕️ You can now catch the full discussion online! Here's a glimpse into what you may have missed ⬇️

Thank you for wonderful colleagues from across the world and a super discussion about Stage 3 lung cancer!

The best physicians at Rutgers Cancer Institute Vignesh Packiam, MD Thomas Jang

HAPPENING NOW! The results of ph2 IRENE study for pts w mTNBC #tnbc with oncolytc virus Pelareorep Oncolytics Biotech and Retifanlimab Incyte. Ohio State Medical Oncology Nicole Williams MD Rutgers Cancer Institute RWJBarnabas Robert Wood Johnson University Hospital OncoAlert #sabcs24

Proud to see RTOG1112 RCT published!. Thanks to so many who helped make this possible. #teamwork ‘Hope the next #SBRT #HCC trials are completed much faster. NRG Oncology Ted Hong Ali Hosni Arndt Vogel Aisling Barry Nice summary of the trial below from Dr. Nina Niu Sanford

It has been a great year for my #HealthcareUnfiltered podcast. 48 total episodes. 55 wonderful guests including 5 CEOs, 4 CMOs, the FDA Commissioner, legal scholars, journalists, patients, advocates, and thought leaders across the spectrum of healthcare and oncology. /1

🌟Incredible team, invaluable lessons!🌟 Kristin Higgins Fumiko Ladd Chino, MD, FASCO William A Hall, MD Salma Jabbour Bryan Traughber Dian Wang, MD., Ph.D. NRG Oncology RTOG Foundation #NRG2025 #radonc

Thanks for highlighting our work that allows for a regimen avoiding FLOT in a biomarker driven definitive gastric cancer population. The results are compelling.

So proud of this work with our awesome Rutgers team and my co-PI Dr. Tim Kennedy Howard S Hochster MD Patrick Boland Rutgers Cancer Institute RWJBarnabas And a big thank you to Merck!

Huge thanks to our fantastic colleagues and collaborators from Emory University Mihir M. Shah and from MontefioreRadOnc Dr. Rafi Kabarriti

Thrilled to announce that our program is expanding from 2–>3 residents/year starting with this upcoming intern class. Thank you to our fearless leaders Thomas Jang and Dr. Barone for their unwavering determination to get this done 🙌

Howard S Hochster MD Salma Jabbour Rutgers Cancer Institute RWJBarnabas Merck We would like to inform you that your post has been published on @Oncodaily. Thank you for sharing! oncodaily.com/blog/233047

What can the future look like for training programs that can attract talented students? Can we rethink part time training? There are ways forward! Proud of this IJROBP - The Red Journal editorial with my awesome colleagues RadOncResearch Farhannah Aly @NickWBucknel and Thomas Dilling and Liz Kenny

authors.elsevier.com/a/1kecf1Hx52K0…

Rutgers Cancer Institute NOW OPEN: “A Phase I/II Study of M3814 and Avelumab in Combination with Hypofractionated Radiation in Patients with Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies.” Salma Jabbour cinj.org/clinical-trial…

Congratulations to Rutgers Cancer Institute & RWJBarnabas experts Dr. Thomas Jang Thomas Jang, Dr. Wadih Arap, and Dr. Renata Pasqualini on being named NJ’s Innovate 100 Leaders by New Jersey Business Magazine! 👏 njbmagazine.com/njb-news-now/n…

Is there a need for further local therapy following chemo-immunotherapy in early #NSCLC for those with complete pathological response? 🫁 Look back on our roundtable with Jean Yannis Perentes, Jonathan Spicer MD PhD, Martin Reck, and Salma Jabbour to explore this question and more ⬇️

Excited to take on this new role and follow in the footsteps of Jeff Bradley, MD!!

Always a privilege to spend a few moments with special colleagues from across the country. Neha Vapiwala Stephen Chun Rutgers Cancer Institute